These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 11051241

  • 1. Functional evaluation of p53 and PTEN gene mutations in gliomas.
    Kato H, Kato S, Kumabe T, Sonoda Y, Yoshimoto T, Kato S, Han SY, Suzuki T, Shibata H, Kanamaru R, Ishioka C.
    Clin Cancer Res; 2000 Oct; 6(10):3937-43. PubMed ID: 11051241
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C, Joyce KA, Thompson-Hehir J, Davies MP, Gibbs FE, Halliwell N, Lloyd BH, Machell Y, Roebuck MM, Salisbury J, Sibson DR, Du Plessis D, Broome J, Rossi ML.
    Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular pathogenesis of malignant gliomas.
    Rasheed BK, Wiltshire RN, Bigner SH, Bigner DD.
    Curr Opin Oncol; 1999 May; 11(3):162-7. PubMed ID: 10328589
    [Abstract] [Full Text] [Related]

  • 7. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas.
    Fults D, Pedone C.
    Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623
    [Abstract] [Full Text] [Related]

  • 8. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
    Nozaki M, Tada M, Kobayashi H, Zhang CL, Sawamura Y, Abe H, Ishii N, Van Meir EG.
    Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
    [Abstract] [Full Text] [Related]

  • 9. Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas.
    Davies MP, Gibbs FE, Halliwell N, Joyce KA, Roebuck MM, Rossi ML, Salisbury J, Sibson DR, Tacconi L, Walker C.
    Br J Cancer; 1999 Mar; 79(9-10):1542-8. PubMed ID: 10188904
    [Abstract] [Full Text] [Related]

  • 10. Molecular genetic analysis of non-astrocytic gliomas.
    Tong CY, Ng HK, Pang JC, Hui AB, Ko HC, Lee JC.
    Histopathology; 1999 Apr; 34(4):331-41. PubMed ID: 10231401
    [Abstract] [Full Text] [Related]

  • 11. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
    Chiariello E, Roz L, Albarosa R, Magnani I, Finocchiaro G.
    Oncogene; 1998 Jan 29; 16(4):541-5. PubMed ID: 9484844
    [Abstract] [Full Text] [Related]

  • 12. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
    Tohma Y, Gratas C, Biernat W, Peraud A, Fukuda M, Yonekawa Y, Kleihues P, Ohgaki H.
    J Neuropathol Exp Neurol; 1998 Jul 29; 57(7):684-9. PubMed ID: 9690672
    [Abstract] [Full Text] [Related]

  • 13. Genetic alterations in pediatric high-grade astrocytomas.
    Cheng Y, Ng HK, Zhang SF, Ding M, Pang JC, Zheng J, Poon WS.
    Hum Pathol; 1999 Nov 29; 30(11):1284-90. PubMed ID: 10571506
    [Abstract] [Full Text] [Related]

  • 14. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF, Miller DC, Koslow M, Newcomb EW.
    J Neurosurg; 1994 Sep 29; 81(3):427-36. PubMed ID: 8057151
    [Abstract] [Full Text] [Related]

  • 15. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
    Boström J, Cobbers JM, Wolter M, Tabatabai G, Weber RG, Lichter P, Collins VP, Reifenberger G.
    Cancer Res; 1998 Jan 01; 58(1):29-33. PubMed ID: 9426052
    [Abstract] [Full Text] [Related]

  • 16. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.
    Bigner SH, Matthews MR, Rasheed BK, Wiltshire RN, Friedman HS, Friedman AH, Stenzel TT, Dawes DM, McLendon RE, Bigner DD.
    Am J Pathol; 1999 Aug 01; 155(2):375-86. PubMed ID: 10433931
    [Abstract] [Full Text] [Related]

  • 17. Presence of allelic loss and PTEN mutations in malignant gliomas from Malay patients.
    Zainuddin N, Jaafar H, Isa MN, Abdullah JM.
    Med J Malaysia; 2004 Oct 01; 59(4):468-79. PubMed ID: 15779579
    [Abstract] [Full Text] [Related]

  • 18. Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood.
    Kraus JA, Felsberg J, Tonn JC, Reifenberger G, Pietsch T.
    Neuropathol Appl Neurobiol; 2002 Aug 01; 28(4):325-33. PubMed ID: 12175345
    [Abstract] [Full Text] [Related]

  • 19. Mutational profile of the PTEN gene in primary human astrocytic tumors and cultivated xenografts.
    Schmidt EE, Ichimura K, Goike HM, Moshref A, Liu L, Collins VP.
    J Neuropathol Exp Neurol; 1999 Nov 01; 58(11):1170-83. PubMed ID: 10560660
    [Abstract] [Full Text] [Related]

  • 20. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W, Xu X, Yang T, Hua Z.
    Chin Med J (Engl); 2000 Jul 01; 113(7):662-6. PubMed ID: 11776043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.